Is this you?
Request access for Peninsula Research Associates with your @peninsularesearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Peninsula Research Associates
Unclaimed profileIndependent Site · California · ~1 sites
Intera lens
ICP 6Lift (cardio sample) 0.17Recruit soph 0.43
Quality Scorecard (1–100)
Overall88Recruit77Ops93Sponsor89Ther93
Performance (observed)
Historical trials
606
Completed
373
Terminated/Withdrawn
61
Completion rate
86%
Active now
160
Phase 2
192
Phase 3
337
Realized enrollment
963,871
First study year
1989
Years active
37
Match confidence
high
Enrollment velocity (inf)
26,051
Therapeutic
Areas
Allergic Rhinitis, Asthma, COPD, COVID-19, Hypertension, Pneumonia, Sinusitis, Vaccines, General Medicine
Specialties
Allergy, asthma, COPD, vaccines, pediatrics
Breadth (conditions)
1,156
Languages
English/Spanish
States
California
Recruitment (web observed)
Trial Finder
Yes
Patient database
N
Recruitment pages
Yes
Advertises recruitment
Yes
Capability notes
High - 200+ trials as PI
Relationships
Sponsors
National Cancer Institute (NCI); SWOG Cancer Research Network; Radiation Therapy Oncology Group; Alliance for Clinical Trials in Oncology; Pfizer; Shire
CROs
Covance; ICON Clinical Research; Medpace, Inc.; PPD Development, LP; Parexel; Teva Branded Pharmaceutical Products R&D, Inc.
Partnerships
Part of Headlands Research (acquired 2022)
Owner / parent
Headlands Research, Inc. (Parent Company)
Funding
Part of Headlands network
Acquisitions
Acquired by Headlands Research (June 2022)
Expansion
Acquired by Headlands Research 2022; part of 20+ site network
Capacity & people
Investigators
—
Coordinators
—
CEO
Lawrence D. Sher, MD, FAAP (Medical Director/Founder)
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Leigh A. Schmidt (Leadership team member)
Emails
leighann.schmidt@pvmedgroup.com, renee.goldstein@pvmedgroup.com, debbie.cappy@peninsularesearch.com
Tech & DCT
CTMS
CRIO
eSource
Yes
eConsent
Yes
Builds tech
N
Tech stack
CRIO clinical trial management system
Recruiting visible
Y
Notes
Founded 1999. ClinicalTrials.gov validation: 7 active recruiting cardiometabolic trials. Established reputation for quality clinical trials. 7,000 sq ft facility with dedicated PBMC lab and vaccine storage. Conducts Phase I-IV trials with broad therapeutic mix including cardiometabolic focus.
Recommendation features (sample indication)
Ind fit 0.30Liftability 0.17Overall88
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.